Gujarat Themis Biosyn Ltd
BSE:506879
Gujarat Themis Biosyn Ltd
BSE:506879
Price:
402.3 INR
0.95%
Market Closed
Updated:
May 14, 2024
Balance Sheet
Balance Sheet Decomposition
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd
| Current Assets | 480.6m |
| Cash & Short-Term Investments | 53.2m |
| Receivables | 360.4m |
| Other Current Assets | 67m |
| Non-Current Assets | 1.5B |
| Long-Term Investments | 457.6m |
| PP&E | 951.5m |
| Other Non-Current Assets | 84.1m |
| Current Liabilities | 160.6m |
| Accounts Payable | 83.8m |
| Other Current Liabilities | 76.8m |
| Non-Current Liabilities | 33.3m |
| Long-Term Debt | 12.1m |
| Other Non-Current Liabilities | 21.2m |
Balance Sheet
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd
Currency: INR
| Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
9
|
2
|
2
|
4
|
45
|
20
|
21
|
276
|
123
|
61
|
|
| Cash |
0
|
0
|
2
|
3
|
36
|
9
|
12
|
237
|
119
|
61
|
|
| Cash Equivalents |
9
|
2
|
0
|
1
|
9
|
11
|
9
|
40
|
5
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
146
|
115
|
37
|
|
| Total Receivables |
20
|
29
|
22
|
70
|
27
|
58
|
202
|
147
|
426
|
355
|
|
| Accounts Receivables |
12
|
24
|
22
|
70
|
27
|
58
|
202
|
147
|
251
|
179
|
|
| Other Receivables |
7
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
175
|
176
|
|
| Inventory |
5
|
3
|
4
|
5
|
5
|
3
|
60
|
60
|
116
|
146
|
|
| Other Current Assets |
0
|
0
|
4
|
3
|
1
|
0
|
3
|
3
|
3
|
9
|
|
| Total Current Assets |
33
|
35
|
31
|
82
|
78
|
83
|
287
|
633
|
784
|
608
|
|
| PP&E Net |
112
|
97
|
94
|
108
|
108
|
156
|
174
|
210
|
321
|
533
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
533
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
114
|
|
| Note Receivable |
13
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
522
|
|
| Long-Term Investments |
0
|
0
|
3
|
3
|
2
|
63
|
155
|
13
|
92
|
0
|
|
| Other Long-Term Assets |
2
|
2
|
18
|
21
|
17
|
26
|
24
|
26
|
28
|
0
|
|
| Total Assets |
160
N/A
|
147
-8%
|
147
0%
|
214
+46%
|
205
-4%
|
328
+60%
|
641
+96%
|
883
+38%
|
1 225
+39%
|
1 663
+36%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
51
|
57
|
55
|
71
|
56
|
56
|
74
|
35
|
66
|
95
|
|
| Short-Term Debt |
20
|
0
|
6
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
22
|
21
|
6
|
60
|
50
|
38
|
8
|
4
|
|
| Other Current Liabilities |
79
|
42
|
11
|
15
|
18
|
12
|
49
|
85
|
98
|
53
|
|
| Total Current Liabilities |
150
|
98
|
93
|
119
|
79
|
128
|
173
|
158
|
172
|
153
|
|
| Long-Term Debt |
60
|
53
|
11
|
7
|
0
|
0
|
32
|
10
|
4
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
0
|
9
|
9
|
10
|
10
|
13
|
|
| Other Liabilities |
3
|
4
|
5
|
6
|
5
|
5
|
5
|
5
|
6
|
6
|
|
| Total Liabilities |
214
N/A
|
155
-28%
|
108
-30%
|
132
+22%
|
84
-37%
|
142
+70%
|
219
+54%
|
183
-16%
|
192
+5%
|
172
-10%
|
|
| Equity | |||||||||||
| Common Stock |
73
|
73
|
73
|
73
|
73
|
73
|
73
|
73
|
73
|
73
|
|
| Retained Earnings |
126
|
81
|
34
|
9
|
48
|
113
|
349
|
627
|
961
|
1 397
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
|
| Total Equity |
53
N/A
|
8
+85%
|
38
N/A
|
82
+114%
|
121
+47%
|
185
+53%
|
422
+128%
|
699
+66%
|
1 033
+48%
|
1 491
+44%
|
|
| Total Liabilities & Equity |
160
N/A
|
147
-8%
|
147
0%
|
214
+46%
|
205
-4%
|
328
+60%
|
641
+96%
|
883
+38%
|
1 225
+39%
|
1 663
+36%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
15
|
15
|
15
|
15
|
15
|
15
|
15
|
73
|
73
|
73
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
